循環腫瘍細胞（CTC）予後技術の世界市場：市場規模・現状・予測

• 英文タイトル：Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST04138 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、循環腫瘍細胞（CTC）予後技術の世界市場について調査・分析し、循環腫瘍細胞（CTC）予後技術の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（腫瘍細胞濃縮、腫瘍細胞検出）、用途別（前立腺がん、乳がん、大腸がん、肺がん、卵巣がん、膵臓がん）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の循環腫瘍細胞（CTC）予後技術市場動向 ・主要企業別マーケットシェア ・循環腫瘍細胞（CTC）予後技術の種類別市場規模2014-2019 （腫瘍細胞濃縮、腫瘍細胞検出） ・循環腫瘍細胞（CTC）予後技術の用途別市場規模2014-2019 （前立腺がん、乳がん、大腸がん、肺がん、卵巣がん、膵臓がん） ・循環腫瘍細胞（CTC）予後技術の北米市場：主要企業・種類別/用途別市場規模 ・循環腫瘍細胞（CTC）予後技術のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・循環腫瘍細胞（CTC）予後技術の中国市場：主要企業・種類別/用途別市場規模 ・循環腫瘍細胞（CTC）予後技術の日本国内市場：主要企業・種類別/用途別市場規模 ・循環腫瘍細胞（CTC）予後技術の東南アジア市場：主要企業・種類別/用途別市場規模 ・循環腫瘍細胞（CTC）予後技術のインド市場：主要企業・種類別/用途別市場規模 ・循環腫瘍細胞（CTC）予後技術の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （AdnaGen、ACDBio、Celula、Epic Sciences、Fluxion Biosciences、Rarecells、Silicon Biosystems、Vitatex） ・循環腫瘍細胞（CTC）予後技術の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Circulating tumor cells (CTCs) are specialized rare cells, which have been shed from a primary solid tumor of the body and circulate in the vasculature system of the body, eventually causing metastasis. CTCs act as the seeds for successive development of additional metastatic tumors in distant organs, which is liable for the majority of cancer-related deaths. On the other hand, these fatal rare cells are capable of providing useful information of cancer patients, since their monitoring and detection is valuable for predicting the response to treatment and prognosis as well as staging of the disease.In 2018, the global Circulating Tumor Cells (CTCs) Prognostic Technologies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Circulating Tumor Cells (CTCs) Prognostic Technologies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Circulating Tumor Cells (CTCs) Prognostic Technologies development in United States, Europe and China.

The key players covered in this study
AdnaGen
ACDBio
Celula
Epic Sciences
Fluxion Biosciences
Rarecells
Silicon Biosystems
Vitatex

Market segment by Type, the product can be split into
Tumor Cell Enrichment
Tumor Cell Detection

Market segment by Application, split into
Prostate Cancer
Breast Cancer
Colorectal Cancer
Lung Cancer
Ovarian Cancer
Pancreatic Cancer

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Circulating Tumor Cells (CTCs) Prognostic Technologies status, future forecast, growth opportunity, key market and key players.
To present the Circulating Tumor Cells (CTCs) Prognostic Technologies development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Circulating Tumor Cells (CTCs) Prognostic Technologies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Growth Rate by Type (2014-2025)
1.4.2 Tumor Cell Enrichment
1.4.3 Tumor Cell Detection
1.5 Market by Application
1.5.1 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Application (2014-2025)
1.5.2 Prostate Cancer
1.5.3 Breast Cancer
1.5.4 Colorectal Cancer
1.5.5 Lung Cancer
1.5.6 Ovarian Cancer
1.5.7 Pancreatic Cancer
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size
2.2 Circulating Tumor Cells (CTCs) Prognostic Technologies Growth Trends by Regions
2.2.1 Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Regions (2014-2025)
2.2.2 Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Manufacturers
3.1.1 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue by Manufacturers (2014-2019)
3.1.2 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Concentration Ratio (CR5 and HHI)
3.2 Circulating Tumor Cells (CTCs) Prognostic Technologies Key Players Head office and Area Served
3.3 Key Players Circulating Tumor Cells (CTCs) Prognostic Technologies Product/Solution/Service
3.4 Date of Enter into Circulating Tumor Cells (CTCs) Prognostic Technologies Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2014-2019)
4.2 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2014-2019)

5 United States
5.1 United States Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size (2014-2019)
5.2 Circulating Tumor Cells (CTCs) Prognostic Technologies Key Players in United States
5.3 United States Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type
5.4 United States Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application

6 Europe
6.1 Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size (2014-2019)
6.2 Circulating Tumor Cells (CTCs) Prognostic Technologies Key Players in Europe
6.3 Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type
6.4 Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application

7 China
7.1 China Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size (2014-2019)
7.2 Circulating Tumor Cells (CTCs) Prognostic Technologies Key Players in China
7.3 China Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type
7.4 China Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application

8 Japan
8.1 Japan Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size (2014-2019)
8.2 Circulating Tumor Cells (CTCs) Prognostic Technologies Key Players in Japan
8.3 Japan Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type
8.4 Japan Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size (2014-2019)
9.2 Circulating Tumor Cells (CTCs) Prognostic Technologies Key Players in Southeast Asia
9.3 Southeast Asia Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type
9.4 Southeast Asia Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application

10 India
10.1 India Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size (2014-2019)
10.2 Circulating Tumor Cells (CTCs) Prognostic Technologies Key Players in India
10.3 India Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type
10.4 India Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application

11 Central & South America
11.1 Central & South America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size (2014-2019)
11.2 Circulating Tumor Cells (CTCs) Prognostic Technologies Key Players in Central & South America
11.3 Central & South America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type
11.4 Central & South America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application

12 International Players Profiles
12.1 AdnaGen
12.1.1 AdnaGen Company Details
12.1.2 Company Description and Business Overview
12.1.3 Circulating Tumor Cells (CTCs) Prognostic Technologies Introduction
12.1.4 AdnaGen Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2014-2019)
12.1.5 AdnaGen Recent Development
12.2 ACDBio
12.2.1 ACDBio Company Details
12.2.2 Company Description and Business Overview
12.2.3 Circulating Tumor Cells (CTCs) Prognostic Technologies Introduction
12.2.4 ACDBio Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2014-2019)
12.2.5 ACDBio Recent Development
12.3 Celula
12.3.1 Celula Company Details
12.3.2 Company Description and Business Overview
12.3.3 Circulating Tumor Cells (CTCs) Prognostic Technologies Introduction
12.3.4 Celula Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2014-2019)
12.3.5 Celula Recent Development
12.4 Epic Sciences
12.4.1 Epic Sciences Company Details
12.4.2 Company Description and Business Overview
12.4.3 Circulating Tumor Cells (CTCs) Prognostic Technologies Introduction
12.4.4 Epic Sciences Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2014-2019)
12.4.5 Epic Sciences Recent Development
12.5 Fluxion Biosciences
12.5.1 Fluxion Biosciences Company Details
12.5.2 Company Description and Business Overview
12.5.3 Circulating Tumor Cells (CTCs) Prognostic Technologies Introduction
12.5.4 Fluxion Biosciences Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2014-2019)
12.5.5 Fluxion Biosciences Recent Development
12.6 Rarecells
12.6.1 Rarecells Company Details
12.6.2 Company Description and Business Overview
12.6.3 Circulating Tumor Cells (CTCs) Prognostic Technologies Introduction
12.6.4 Rarecells Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2014-2019)
12.6.5 Rarecells Recent Development
12.7 Silicon Biosystems
12.7.1 Silicon Biosystems Company Details
12.7.2 Company Description and Business Overview
12.7.3 Circulating Tumor Cells (CTCs) Prognostic Technologies Introduction
12.7.4 Silicon Biosystems Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2014-2019)
12.7.5 Silicon Biosystems Recent Development
12.8 Vitatex
12.8.1 Vitatex Company Details
12.8.2 Company Description and Business Overview
12.8.3 Circulating Tumor Cells (CTCs) Prognostic Technologies Introduction
12.8.4 Vitatex Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2014-2019)
12.8.5 Vitatex Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Circulating Tumor Cells (CTCs) Prognostic Technologies Key Market Segments
Table Key Players Circulating Tumor Cells (CTCs) Prognostic Technologies Covered
Table Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Market Share by Type 2014-2025
Figure Tumor Cell Enrichment Figures
Table Key Players of Tumor Cell Enrichment
Figure Tumor Cell Detection Figures
Table Key Players of Tumor Cell Detection
Table Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Growth by Application 2014-2025 (Million US$)
Figure Prostate Cancer Case Studies
Figure Breast Cancer Case Studies
Figure Colorectal Cancer Case Studies
Figure Lung Cancer Case Studies
Figure Ovarian Cancer Case Studies
Figure Pancreatic Cancer Case Studies
Figure Circulating Tumor Cells (CTCs) Prognostic Technologies Report Years Considered
Table Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size 2014-2025 (Million US$)
Figure Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Regions 2014-2025 (Million US$)
Table Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Regions 2014-2019 (Million US$)
Table Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Regions 2014-2019
Figure Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Regions 2014-2019
Figure Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Regions 2019
Table Market Top Trends
Table Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Manufacturers (2014-2019)
Figure Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Manufacturers in 2018
Table Global Circulating Tumor Cells (CTCs) Prognostic Technologies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Circulating Tumor Cells (CTCs) Prognostic Technologies Product/Solution/Service
Table Date of Enter into Circulating Tumor Cells (CTCs) Prognostic Technologies Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2014-2019) (Million US$)
Table Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Share by Type (2014-2019)
Figure Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Market Share by Type (2014-2019)
Table Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2014-2019) (Million US$)
Table Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Share by Application (2014-2019)
Figure Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Market Share by Application (2014-2019)
Figure Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue Market Share by Application in 2018
Figure United States Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size 2014-2019 (Million US$)
Table United States Key Players Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue (2018-2019) (Million US$)
Table United States Key Players Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share (2018-2019)
Table United States Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2014-2019) (Million US$)
Table United States Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Type (2014-2019)
Table United States Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2014-2019) (Million US$)
Table United States Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Application (2014-2019)
Figure Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size 2014-2019 (Million US$)
Table Europe Key Players Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue (2018-2019) (Million US$)
Table Europe Key Players Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share (2018-2019)
Table Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2014-2019) (Million US$)
Table Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Type (2014-2019)
Table Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2014-2019) (Million US$)
Table Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Application (2014-2019)
Figure China Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size 2014-2019 (Million US$)
Table China Key Players Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue (2018-2019) (Million US$)
Table China Key Players Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share (2018-2019)
Table China Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2014-20189) (Million US$)
Table China Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Type (2014-2019)
Table China Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2014-2019) (Million US$)
Table China Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Application (2014-2019)
Figure Japan Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size 2014-2019 (Million US$)
Table Japan Key Players Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue (2018-2019) (Million US$)
Table Japan Key Players Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share (2018-2019)
Table Japan Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2014-2019) (Million US$)
Table Japan Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Type (2014-2019)
Table Japan Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2014-2019) (Million US$)
Table Japan Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Application (2014-2019)
Figure Southeast Asia Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share (2018-2019)
Table Southeast Asia Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Type (2014-2019)
Table Southeast Asia Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Application (2014-2019)
Figure India Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size 2014-2019 (Million US$)
Table India Key Players Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue (2018-2019) (Million US$)
Table India Key Players Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share (2018-2019)
Table India Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2014-2019) (Million US$)
Table India Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Type (2014-2019)
Table India Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2014-2019) (Million US$)
Table India Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Application (2014-2019)
Figure Central & South America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share (2018-2019)
Table Central & South America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2014-2019) (Million US$)
Table Central & South America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Type (2014-2019)
Table Central & South America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2014-2019) (Million US$)
Table Central & South America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Application (2014-2019)
Table AdnaGen Company Details
Table AdnaGen Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2014-2019) (Million US$)
Figure AdnaGen Revenue Growth Rate in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2014-2019)
Table AdnaGen Recent Development
Table ACDBio Company Details
Table ACDBio Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2014-2019)(Million US$)
Figure ACDBio Revenue Growth Rate in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2014-2019)
Table ACDBio Recent Development
Table Celula Company Details
Table Celula Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2014-2019)(Million US$)
Figure Celula Revenue Growth Rate in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2014-2019)
Table Celula Recent Development
Table Epic Sciences Company Details
Table Epic Sciences Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2014-2019)(Million US$)
Figure Epic Sciences Revenue Growth Rate in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2014-2019)
Table Epic Sciences Recent Development
Table Fluxion Biosciences Company Details
Table Fluxion Biosciences Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2014-2019)(Million US$)
Figure Fluxion Biosciences Revenue Growth Rate in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2014-2019)
Table Fluxion Biosciences Recent Development
Table Rarecells Company Details
Table Rarecells Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2014-2019)(Million US$)
Figure Rarecells Revenue Growth Rate in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2014-2019)
Table Rarecells Recent Development
Table Silicon Biosystems Company Details
Table Silicon Biosystems Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2014-2019)(Million US$)
Figure Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2014-2019)
Table Silicon Biosystems Recent Development
Table Vitatex Company Details
Table Vitatex Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2014-2019)(Million US$)
Figure Vitatex Revenue Growth Rate in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2014-2019)
Table Vitatex Recent Development
Table Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Regions (Million US$) 2019-2025
Figure Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Share by Regions (2019-2025)
Figure Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Share by Regions in 2025
Figure United States Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Forecast (2019-2025)(Million USD)
Figure Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Forecast (2019-2025)(Million USD)
Figure China Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Forecast (2019-2025)(Million USD)
Figure Japan Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Forecast (2019-2025)(Million USD)
Figure India Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Forecast (2019-2025)(Million USD)
Table Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Product (2019-2025) (Million US$)
Figure Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Product (2019-2025)
Figure Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Product in 2025
Table Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2019-2025) (Million US$)
Figure Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2019-2025)
Figure Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---